Point-of-care cell therapy manufacturing; it’s not for everyone

The use of cellular therapies to treat cancer, inherited immune deficiencies, hemoglobinopathies and viral infections is growing rapidly. The increased interest in cellular therapies has led to the development of reagents and closed-system automated instruments for the production of these therapies....

Descripción completa

Detalles Bibliográficos
Autores principales: Stroncek, David F., Somerville, Robert P. T., Highfill, Steven L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761342/
https://www.ncbi.nlm.nih.gov/pubmed/35033098
http://dx.doi.org/10.1186/s12967-022-03238-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761342/
https://www.ncbi.nlm.nih.gov/pubmed/35033098
http://dx.doi.org/10.1186/s12967-022-03238-5

Ejemplares similares